Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fenner

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Bailliere'S Clinical Rheumatology|June 1, 1992
The role of cytokines and their inhibitors in arthritisJ M Dayer, H Fenner
Archiv Der Pharmazie|April 1, 1978
[10-omega-dimethylaminopropylpyrimido [5,4-b] [1,4]-benzothiazinedione, a promazin analogue of thiaflavin (author's transl)]H Fenner, R W Grauert
Onkologie|November 5, 2002
Chemotherapy for breast cancer brain metastasesM H Fenner, K Possinger
Expert Opinion on Investigational Drugs|July 12, 2005
Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancerMartin H Fenner, Elena Elstner
Rheumatology (Oxford, England)|January 4, 2001
Links between joint damage and disabilityR Rau, G Herborn, H Fenner
Arzneimittel-Forschung|January 1, 1985
[The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application]H Fenner, O Schiemann, I Gikalov
Archiv Der Pharmazie|July 1, 1978
[Quinolylidene derivatives (author's transl)]F Eiden, R Wendt, H Fenner
Arzneimittel-Forschung|August 1, 1974
[Negative inotropic effect of tricyclic antidepressants on the isolated right ventricular papillary muscle of the cat]H Fenner, J Neye, G Biamino
Arthritis and Rheumatism|February 7, 2003
Early and aggressive treatment affects the association of HLA-DRB1 genes with progression of joint damage: comment on the article by Lard et alR Rau, G Herborn, H Fenner
Expert Opinion on Investigational Drugs|March 28, 2008
Targeted therapies for patients with germ cell tumorsMartin H Fenner, Gernot Beutel, Viktor Grünwald
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Bailliere'S Clinical Rheumatology|June 1, 1992
The role of cytokines and their inhibitors in arthritisJ M Dayer, H Fenner
Archiv Der Pharmazie|April 1, 1978
[10-omega-dimethylaminopropylpyrimido [5,4-b] [1,4]-benzothiazinedione, a promazin analogue of thiaflavin (author's transl)]H Fenner, R W Grauert
Onkologie|November 5, 2002
Chemotherapy for breast cancer brain metastasesM H Fenner, K Possinger
Expert Opinion on Investigational Drugs|July 12, 2005
Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancerMartin H Fenner, Elena Elstner
Rheumatology (Oxford, England)|January 4, 2001
Links between joint damage and disabilityR Rau, G Herborn, H Fenner
Arzneimittel-Forschung|January 1, 1985
[The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application]H Fenner, O Schiemann, I Gikalov
Archiv Der Pharmazie|July 1, 1978
[Quinolylidene derivatives (author's transl)]F Eiden, R Wendt, H Fenner
Arzneimittel-Forschung|August 1, 1974
[Negative inotropic effect of tricyclic antidepressants on the isolated right ventricular papillary muscle of the cat]H Fenner, J Neye, G Biamino
Arthritis and Rheumatism|February 7, 2003
Early and aggressive treatment affects the association of HLA-DRB1 genes with progression of joint damage: comment on the article by Lard et alR Rau, G Herborn, H Fenner
Expert Opinion on Investigational Drugs|March 28, 2008
Targeted therapies for patients with germ cell tumorsMartin H Fenner, Gernot Beutel, Viktor Grünwald
Pageof 8